Vincenzi B - Search Results

1

Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network.

Stacchiotti S, Palassini E, Sanfilippo R, Vincenzi B, Arena MG, Bochicchio AM, De Rosa P, Nuzzo A, Turano S, Morosi C, Dei Tos AP, Pilotti S, Casali PG. Stacchiotti S, et al. Among authors: vincenzi b. Ann Oncol. 2012 Feb;23(2):501-8. doi: 10.1093/annonc/mdr066. Epub 2011 Apr 4. Ann Oncol. 2012. PMID: 21464156 Free article.

2

Gemcitabine-induced atrial fibrillation: a hitherto unreported manifestation of drug toxicity.

Santini D, Tonini G, Abbate A, Di Cosimo S, Gravante G, Vincenzi B, Campisi C, Patti G, Di Sciascio G. Santini D, et al. Among authors: vincenzi b. Ann Oncol. 2000 Apr;11(4):479-81. doi: 10.1023/a:1008380208045. Ann Oncol. 2000. PMID: 10847470 Free article.

3

Paclitaxel, carboplatin and gemcitabine combination as induction chemotherapy for stage IIIA N2 bulky non-small cell lung cancer.

Giannitto GC, Giuffrida D, Pappalardo A, Russo A, Vincenzi B, Saita S, Potenza E, Marletta F, La Venia G, Castorina S, Bordonaro R. Giannitto GC, et al. Among authors: vincenzi b. Oncology. 2005;69(4):295-300. doi: 10.1159/000089679. Epub 2005 Nov 9. Oncology. 2005. PMID: 16282709 Clinical Trial.

4

Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients.

Vincenzi B, Santini D, Russo A, Silletta M, Gavasci M, Battistoni F, Di Cuonzo G, Rocci L, Gebbia N, Tonini G. Vincenzi B, et al. Ann Oncol. 2006 May;17(5):835-41. doi: 10.1093/annonc/mdl031. Epub 2006 Feb 28. Ann Oncol. 2006. PMID: 16507564 Free article.

5

A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients.

Santini D, Virzí V, Vincenzi B, Rocci L, Leoni V, Tonini G. Santini D, et al. Among authors: vincenzi b. Ann Oncol. 2007 Mar;18(3):576-80. doi: 10.1093/annonc/mdl440. Epub 2006 Dec 8. Ann Oncol. 2007. PMID: 17158771 Free article. Clinical Trial.

6

Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer.

Santini D, Perrone G, Vincenzi B, Lai R, Cass C, Alloni R, Rabitti C, Antinori A, Vecchio F, Morini S, Magistrelli P, Coppola R, Mackey JR, Tonini G. Santini D, et al. Among authors: vincenzi b. Ann Oncol. 2008 Apr;19(4):724-8. doi: 10.1093/annonc/mdm576. Epub 2008 Jan 10. Ann Oncol. 2008. PMID: 18187485 Free article.

7

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance.

Addeo R, Caraglia M, Bellini S, Abbruzzese A, Vincenzi B, Montella L, Miragliuolo A, Guarrasi R, Lanna M, Cennamo G, Faiola V, Del Prete S. Addeo R, et al. Among authors: vincenzi b. J Clin Oncol. 2010 Feb 1;28(4):543-8. doi: 10.1200/JCO.2008.20.8199. Epub 2009 Oct 19. J Clin Oncol. 2010. PMID: 19841330 Clinical Trial.

8

PML down-regulation in soft tissue sarcomas.

Vincenzi B, Perrone G, Santini D, Grosso F, Silletta M, Frezza A, Rossi S, Russo A, Rabitti C, Gebbia N, Badalamenti G, Casali P, Muda AO, Dei Tos AP, Tonini G. Vincenzi B, et al. J Cell Physiol. 2010 Sep;224(3):644-8. doi: 10.1002/jcp.22161. J Cell Physiol. 2010. PMID: 20578240

9

Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients.

Vincenzi B, Galluzzo S, Santini D, Rocci L, Loupakis F, Correale P, Addeo R, Zoccoli A, Napolitano A, Graziano F, Ruzzo A, Falcone A, Francini G, Dicuonzo G, Tonini G. Vincenzi B, et al. Ann Oncol. 2011 May;22(5):1141-1146. doi: 10.1093/annonc/mdq550. Epub 2010 Nov 29. Ann Oncol. 2011. PMID: 21115601 Free article.

10

PML expression in soft tissue sarcoma: prognostic and predictive value in alkylating agents/antracycline-based first line therapy.

Vincenzi B, Santini D, Schiavon G, Frezza AM, Silletta M, Crucitti P, Casali P, Dei Tos AP, Rossi S, Rizzo S, Badalamenti G, Tomasino RM, Russo A, Butrynski JE, Tonini G. Vincenzi B, et al. J Cell Physiol. 2012 Apr;227(4):1657-62. doi: 10.1002/jcp.22889. J Cell Physiol. 2012. PMID: 21678421

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

492 results

Search Page